GALVmed aims to make a significant contribution towards transformational change in the smallholder livestock health landscape by developing a portfolio of high impact products and initiating a range of private sector market initiatives operating at scale in the smallholder sector.
About GALVmedGALVmed is keeping a close watch on the COVID-19 situation across the world and is adopting precautionary measures in line with government guidance. GALVmed staff have been instructed to follow regional advice and work from home in keeping with local government recommendations. GALVmed is also cancelling all business travel and face-to-face meetings until further notice. This is to minimize health risks to our staff, their families, partners and society at large.
It is our aim to maintain business-as-usual, but ask for your understanding should the current COVID-19 epidemic lead to any delays or disruptions in business matters.
Foot and Mouth Disease is a highly contagious livestock disease. Morbidity levels can reach 100%
International and regional trade of animals and animal products are compromised and disrupted, leading to severe socio-economic consequences
Vaccination is proven to effectively control FMD
The FMD Project encourages the development of a private sector model for buying and distributing high-quality FMD vaccines
Product development
GALVmed specialises in product development partnerships uniquely established to translate global research progress into tangible livestock disease control tools for the developing world.
Policy and advocacy
The policy environment is a key determinant in the successful translation of research products to livestock health solutions that are sustainably available to smallholder farmers.
2020-03-17
World Veterinary Day provides a great opportunity to celebrate the work of veterinarians and other veterinary service providers around the world. And GALVmed wants to take the opportunity to recognize the contributions of our many …
On 22 January 2020, GALVmed and AgResults launched the AgResults Foot and Mouth Disease Vaccine Challenge Project, an eight-year, US$15.8 million prize competition that encourages the development and uptake of high-quality FMD vaccines tailored to …
The AgResults Foot and Mouth Disease (FMD) Vaccine Challenge Project is an eight-year, US$15.8 million prize competition that supports the development and uptake of high-quality FMD vaccines tailored to meet the needs of Eastern …
